Pepaxto (Melphalan Flufenamide Vials) 20 mg

Pepaxto (melphalan flufenamide) is an injectable prescription medication used in combination with dexamethasone for certain adult patients with relapsed or refractory multiple myeloma. This chemotherapy agent is administered by healthcare professionals in clinical settings. melphalan flufenamide 20 mg vial

Strength

20 mg

Manufacturer / TM Owner

Oncopeptides

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Melphalan flufenamide is used in combination with dexamethasone to treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. It belongs to the class of chemotherapy drugs known as alkylating agents. Patients often ask, what is melphalan flufenamide used for, and it is specifically indicated for this challenging-to-treat blood cancer scenario.

Side Effects

As a chemotherapy agent, melphalan flufenamide works by interfering with the growth of cancer cells, helping to slow or stop their spread. Patients may experience effects such as fatigue or changes in blood cell counts during treatment. These effects are typically monitored closely by healthcare providers.

Precautions & Warnings

Melphalan flufenamide is administered under medical supervision due to its potent effects. Patients should discuss their full medical history with their healthcare provider, including any infections or blood disorders. Regular blood tests are essential to monitor for potential side effects.

Avoid Interactions

Melphalan flufenamide may interact with other medications, including certain chemotherapy drugs, blood thinners, or immune suppressants. Alcohol and other substances that affect the liver should be used cautiously. Patients should inform their healthcare provider about all medications and supplements they are taking.

References

Frequently Asked Questions

Melphalan flufenamide is used in combination with dexamethasone to treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.

Melphalan flufenamide is administered as an intravenous injection by healthcare professionals in a clinical setting.

Common side effects may include fatigue, changes in blood cell counts, and other effects typically monitored during treatment.

Patients should inform their healthcare provider about all medications and supplements they are taking, as interactions may occur.

Yes, melphalan flufenamide is a chemotherapy agent classified as an alkylating drug.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.